You are a patient or parent of a child diagnosed with Attention Deficit / Hyperactivity Disorder (ADHD) and your doctor has offered you treatment with Methylphenidate marketed as Concerta®, Quasym®, Medininet® or Ritalin®.
You want to access information about this drug that can enlighten you in your choices, know what are the expected effects, the risks associated with this prescription.
The National Agency for the Safety of Medicines has published a brochure specifically intended to inform patients and parents, as well as an analysis report providing an update on the prescription of methylphenidate in France.
We invite you to read these documents whose source is reliable.
Related posts:
New Lambda Variant Spreads in 29 Countries, There are 3 Common Symptoms Sufferers Feel
Demand for a vaccination card postponed for mass events | Government | Economy
Rodiabet Patient Hour Registration Now Open with Special Guest Dr. Mihai Comșa - Learn About Carbohy...
Not Only Long Covid, People Can Also Experience Long Flu
